Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2012202085B2 - Conserved HBV and HCV sequences useful for gene silencing - Google Patents
[go: Go Back, main page]

AU2012202085B2 - Conserved HBV and HCV sequences useful for gene silencing - Google Patents

Conserved HBV and HCV sequences useful for gene silencing

Info

Publication number
AU2012202085B2
AU2012202085B2 AU2012202085A AU2012202085A AU2012202085B2 AU 2012202085 B2 AU2012202085 B2 AU 2012202085B2 AU 2012202085 A AU2012202085 A AU 2012202085A AU 2012202085 A AU2012202085 A AU 2012202085A AU 2012202085 B2 AU2012202085 B2 AU 2012202085B2
Authority
AU
Australia
Prior art keywords
gene silencing
sequences useful
hcv sequences
conserved hbv
hbv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012202085A
Other versions
AU2012202085A1 (en
Inventor
Liat Mintz
Catherine Pachuk
Chandrasekhar Satishchandran
Vincent Zurawski Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alnylam Pharmaceuticals Inc
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005319306A external-priority patent/AU2005319306B9/en
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Priority to AU2012202085A priority Critical patent/AU2012202085B2/en
Publication of AU2012202085A1 publication Critical patent/AU2012202085A1/en
Application granted granted Critical
Publication of AU2012202085B2 publication Critical patent/AU2012202085B2/en
Priority to AU2013257445A priority patent/AU2013257445B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2012202085A 2004-12-22 2012-04-11 Conserved HBV and HCV sequences useful for gene silencing Ceased AU2012202085B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2012202085A AU2012202085B2 (en) 2004-12-22 2012-04-11 Conserved HBV and HCV sequences useful for gene silencing
AU2013257445A AU2013257445B2 (en) 2004-12-22 2013-11-13 Conserved HBV and HCV sequences useful for gene silencing

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/638,294 2004-12-22
AU2005319306A AU2005319306B9 (en) 2004-12-22 2005-12-20 Conserved HBV and HCV sequences useful for gene silencing
AU2012202085A AU2012202085B2 (en) 2004-12-22 2012-04-11 Conserved HBV and HCV sequences useful for gene silencing

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2005319306A Division AU2005319306B9 (en) 2004-12-22 2005-12-20 Conserved HBV and HCV sequences useful for gene silencing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2013257445A Division AU2013257445B2 (en) 2004-12-22 2013-11-13 Conserved HBV and HCV sequences useful for gene silencing

Publications (2)

Publication Number Publication Date
AU2012202085A1 AU2012202085A1 (en) 2012-05-03
AU2012202085B2 true AU2012202085B2 (en) 2013-08-08

Family

ID=

Similar Documents

Publication Publication Date Title
IL172268A0 (en) Conserved hbv and hcv sequences useful for gene silencing
AU2003256334A1 (en) Inhibitors of hcv ns5b polymerase
AU2003265255A1 (en) Inhibitors of hcv ns5b polymerase
GB2407091B (en) Allele-specific siRNA-mediated gene silencing
ZA200607134B (en) Inhibitors of hepatitis C virus NS3 protease
PL1799028T3 (en) Gene silencing
EP1684787A4 (en) Hepatitis c virus inhibitors
ZA200701846B (en) Monocot ahass sequences and methods of use
AP2585A (en) Macrocyclic inhibitors of hepatitis C virus
IL182339A0 (en) Hcv ns3-ns4a protease inhibition
IL171800A (en) Hcv ns5b inhibitors and methods associated therewith
IL240244A0 (en) Macrocyclic inhibitors of hepatitis c virus
IL169777A0 (en) Viral polymerase inhibitors
PL1912997T3 (en) Macrocyclic inhibitors of hepatitis c virus
IL188281A0 (en) Macrocyclic inhibitors of hepatitis c virus
AU2012202085B2 (en) Conserved HBV and HCV sequences useful for gene silencing
AU2013257445A1 (en) Conserved HBV and HCV sequences useful for gene silencing
WO2006074437A8 (en) Nucleotide sequences encoding ramosa3 and sister of ramosa3 and methods of use for same
HK1105663A (en) Sirna-mediated gene silencing of alpha synuclein
HK1095838A (en) Inhibitors of hepatitis c virus ns3 protease
AU2005901631A0 (en) Genetic sequences and uses therefor
AU2004903497A0 (en) Hepatitis B virus polymerase
HK1121390A (en) Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
HK1107996A (en) Sirna silencing of apolipoprotein b
HK1094429A (en) Hepatitis c virus inhibitors